04/04/2026 - Events
The awards were presented at the 43rd Pneumological Day, held in Sabadell, in the Vallès Occidental, from April 16 to 18. The winning project analyzes the clinical benefits of an oscillating positive expiratory pressure device in patients with bronchiectasis. A study led by the Bronchiectasis Unit of the Pneumology Department at the Hospital del Mar has won two awards at the Pneumological Day organized by the Societat Catalana de Pneumologia (SOCAP).
30/04/2026 - General information
She is one of the five researchers selected in this year's edition of these prestigious awards. The L'Oréal-Unesco "For Women in Science" programme seeks to promote and recognise the work of women scientists in Spain and to encourage scientific vocations among younger generations. The L'Oréal-Unesco "For Women in Science" research awards have selected Dr Sara Mederos, coordinator of the Neural Computation Laboratory at the Hospital del Mar Research Institute, in this year's edition of the awards. The award ceremony took place in Madrid on 29 April.
Més informació "Dr Sara Mederos wins one of the L’Oréal-Unesco “For Women in Science”"
29/04/2026 - Press release
Evidence indicates that Chronic Obstructive Pulmonary Disease (COPD) manifests clinically in different ways in men and women. According to a collaborative study led by the Hospital del Mar Research Institute, the possible cause is that the mechanisms of this disease differ according to the patient's sex. Several metabolites present in the blood differ between the two groups, which implies that the disease has different mechanisms depending on biological sex. This finding also identifies potential therapeutic targets for addressing personalised treatment according to the patient's sex
Més informació "Study shows that COPD mechanisms differ according to biological sex"
27/04/2026 - Press release
The Spanish Ataxia Telangiectasia Families Association (AEFAT) has signed a two-year collaboration agreement with the Hospital del Mar Research Institute (HMRIB) to promote a study aimed at advancing research into potential treatments for this disease. It is a condition that affects children and adolescents, caused by the mutation of a gene that generates a toxic protein linked to DNA repair.
23/04/2026 - Events
Sant Jordi, the day of the book and the rose, has once again left us with images that show how important this celebration is. Solidarity roses, heartfelt books, and the first edition of the Sant Jordi short story contest. The contest jury awarded the story Carmela by Centre Fòrum nurse Maria Ángeles Fernández Rivera as the best among the twenty texts submitted. In second place, Laia Cano Márquez, from the Hospital del Mar Research Institute, with the story Allò que no es veu, and in third place, Rut Fuentes Fernández, TCAI at Centre Dr. Emili Mira, with Sant Jordi in the kingdom of silence. The special prize for the stories with the most 'likes' on the intranet went to Isabel Márquez Romero, nurse at CAEM, for Allò que roman, and to Carmen Navarro Fernández, nurse at Centre Esperança, for Second chances.
22/04/2026 - Press release
The project, led by INCLIVA, the Hospital del Mar Research Institute and the Vall d'Hebron Institute of Oncology, has developed models based on artificial intelligence and the use of liquid biopsy to molecularly characterize patients with a more aggressive phenotype. It has also been discovered that the tumor microenvironment influences resistance to chemotherapy, opening new avenues for treatments targeting both tumor cells and their surrounding environment. Among its most outstanding results, the project has enabled the development of a relapse prediction system for patients in different scenarios using artificial intelligence and deep learning, which uses models called artificial neural networks inspired by the functioning of the human brain, together with the analysis of visual images of biological tissues observed under the microscope. This helps identify high-risk patients
23/04/2026 - General information
20/04/2026 - Events
On Wednesday, 15th April, a successful initiative to attract international postdoctoral talent to the Hospital del Mar Research Institute Barcelona (HMRIB) took place. The event, organized by Chris George and the Research Grants and Contracts Office (RGCO), was held online and saw 95 registered attendees from 61 different international institutes. The session began with a welcome address by Judit Cubedo, Managing Director of the Institute, followed by a presentation by Ismael Ávila, Head of Technology Transfer, who provided an overview of the HMRIB research environment and infrastructure. His talk highlighted the state-of-the-art facilities, the institute's translational capabilities, and the collaborative atmosphere within the PRBB research park.
Més informació "HMRIB Hosts Successful Event to Attract International Postdoctoral Talent"
20/04/2026 - General information
Initial data from this European programme, which is being carried out in Santa Coloma de Gramenet and in the Sant Martí district of Barcelona, indicate that nearly 33% of participating women have received a diagnosis of depression, compared with 20% in the case of men. The European MENTBEST project, which is being carried out in Santa Coloma de Gramenet and in the Sant Martí district of Barcelona, has now reached its halfway point after 12 months. The initial data from the study, unique in Spain and being conducted in five European countries, promoted by the European Union, show a higher prevalence of mental health problems in women.
17/04/2026 - Press release
After more than a decade of research, a new-generation CAR-T therapy developed by VHIO, in collaboration with the Hospital del Mar Research Institute, has been administered to patients for the first time in a phase 1 clinical trial. This breakthrough has been made possible thanks to continued funding from the Spanish Association Against Cancer (Asociación Española Contra el Cáncer), with the support of Ausonia, and from the Breast Cancer Research Foundation to the laboratory of Dr Joaquín Arribas at VHIO. This CAR-T combines recognition of the p95HER2 protein, which is specific to one third of HER2+ tumours, with the secretion of a bispecific antibody to activate the immune system and enhance the anti-tumour response in HER2+ solid tumours. The academic phase 1 clinical trial CATHERINE will test this therapy for the first time in patients with solid tumours overexpressing HER2 who have exhausted all therapeutic options and are candidates to receive a cell therapy. The aim is to assess safety and preliminary efficacy. The study, to be carried out at VHIO and Hospital del Mar, is funded by the Spanish Association Against Cancer, with the support of Ausonia and the Carlos III Health Institute.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
